HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[S-1-based chemotherapy for recurrent gastric cancer with peritoneal dissemination resulting in long-term survival--report of a case].

Abstract
A 52-year-old man underwent distal gastrectomy for gastric cancer in July 2000. In July 2005, abdominal CT and barium study of the colon revealed peritoneal recurrence, and chemotherapy of S-1 was started. Within 2 courses, the serum CEA level increased, so combination chemotherapy of S-1 and cisplatin (CDDP) was begun. After 7 courses, the regimen was switched to S-1+paclitaxel (PTX). However, the patient developed digital numbness within 8 courses and single-agent chemotherapy with S-1 was restarted. In July 2007, he developed abdominal distension, and abdominal CT showed a large amount of ascites. S-1+CDDP was administered again, however, and we had to change the regimen within 3 courses due to fatigue and appetite loss. S-1 was restarted, but soon severe fatigue and appetite loss restricted the use of chemotherapeutic agents, and he died in December. This patient had been alive for 2 years and 5 months since peritoneal recurrence was diagnosed. We concluded that S-1-based sequential chemotherapy was effective for recurrent gastric cancer.
AuthorsTomoyuki Wakahara, Akihiro Toyokawa, Ayako Tomono, Soichiro Tani, Taku Yamamichi, Narutomo Nishioka, Hidetoshi Gon, Hironori Yamashita, Takayoshi Nakajima, Kiyonori Kanemitsu, Tsuyoshi Takahashi, Toyokazu Okuda, Ken-ichi Tanaka, Tadashi Tsukamoto, Yutaka Hamabe, Takeshi Iwasaki, Takeshi Ishida
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 37 Issue 7 Pg. 1361-4 (Jul 2010) ISSN: 0385-0684 [Print] Japan
PMID20647727 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
Topics
  • Antimetabolites, Antineoplastic (therapeutic use)
  • Drug Combinations
  • Fatal Outcome
  • Humans
  • Male
  • Middle Aged
  • Oxonic Acid (therapeutic use)
  • Peritoneal Neoplasms (diagnostic imaging, drug therapy, secondary)
  • Recurrence
  • Stomach Neoplasms (diagnostic imaging, drug therapy, pathology)
  • Tegafur (therapeutic use)
  • Time Factors
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: